Predicted Strain Coverage of a New Meningococcal Multicomponent Vaccine (4CMenB) in Spain: Analysis of the Differences with Other European Countries.

BACKGROUND:A novel meningococcal multicomponent vaccine, 4CMenB (Bexsero®), has been approved in Europe, Canada, Australia and US. The potential impact of 4CMenB on strain coverage is being estimated by using Meningococcal Antigen Typing System (MATS), an ELISA assay which measures vaccine antigen e...

Full description

Bibliographic Details
Main Authors: Raquel Abad, Verónica Medina, Maria Stella, Giuseppe Boccadifuoco, Maurizio Comanducci, Stefania Bambini, Alessandro Muzzi, Julio A Vázquez
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4780694?pdf=render